Vizgen Announces $85.2 Million Series C Financing

Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced the closing of $85.2 million Series C financing. The financing was led by Blue Water Life Science Advisors and ARCH Venture Partners. Also participating in the round were new and existing investors Sofina, Northpond Ventures, Tao Capital Partners, Novalis LifeSciences, David Walt, and others.